Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Improving Outcomes in Fistula Intervention: A prospective, patient blinded, phase 3, randomised controlled trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)

Next Previous
Trial Profile

Improving Outcomes in Fistula Intervention: A prospective, patient blinded, phase 3, randomised controlled trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial disorders; Restenosis
  • Focus Therapeutic Use
  • Acronyms DeVA

Most Recent Events

  • 02 Apr 2019 Status changed from recruiting to active, no longer recruiting.
  • 07 Nov 2018 Planned End Date changed from 29 Oct 2018 to 30 Apr 2020.
  • 07 Nov 2018 Status has been changed to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top